Sensorion Ownership
| ALSEN Stock | EUR 0.55 0.01 1.79% |
Sensorion |
Sensorion Stock Ownership Analysis
About 49.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. Sensorion SA recorded a loss per share of 0.29. The entity had not issued any dividends in recent years. Sensorion SA, a clinical-stage biopharmaceutical company, develops therapies for the treatment of inner ear disorders in France. The company was founded in 2009 and is headquartered in Montpellier, France. SENSORION operates under Biotechnology classification in France and is traded on Paris Stock Exchange. It employs 33 people. For more info on Sensorion SA please contact Nawal Ouzren at 33 4 67 20 77 30 or go to https://www.sensorion.com.Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Sensorion Stock Analysis
When running Sensorion's price analysis, check to measure Sensorion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sensorion is operating at the current time. Most of Sensorion's value examination focuses on studying past and present price action to predict the probability of Sensorion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sensorion's price. Additionally, you may evaluate how the addition of Sensorion to your portfolios can decrease your overall portfolio volatility.